208 related articles for article (PubMed ID: 24659747)
1. Healing scars: targeting pericytes to treat fibrosis.
Greenhalgh SN; Conroy KP; Henderson NC
QJM; 2015 Jan; 108(1):3-7. PubMed ID: 24659747
[TBL] [Abstract][Full Text] [Related]
2. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
Kramann R; DiRocco DP; Humphreys BD
J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
Chang FC; Chou YH; Chen YT; Lin SL
J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
[TBL] [Abstract][Full Text] [Related]
4. The role played by perivascular cells in kidney interstitial injury.
Rojas A; Chang FC; Lin SL; Duffield JS
Clin Nephrol; 2012 May; 77(5):400-8. PubMed ID: 22551886
[TBL] [Abstract][Full Text] [Related]
5. Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
Cipriani P; Di Benedetto P; Ruscitti P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Guggino G; Zazzeroni F; Alesse E; Triolo G; Giacomelli R
J Rheumatol; 2016 Jul; 43(7):1340-9. PubMed ID: 27252423
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.
Campanholle G; Ligresti G; Gharib SA; Duffield JS
Am J Physiol Cell Physiol; 2013 Apr; 304(7):C591-603. PubMed ID: 23325411
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of fibrosis: the role of the pericyte.
Schrimpf C; Duffield JS
Curr Opin Nephrol Hypertens; 2011 May; 20(3):297-305. PubMed ID: 21422927
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.
Wu CF; Chiang WC; Lai CF; Chang FC; Chen YT; Chou YH; Wu TH; Linn GR; Ling H; Wu KD; Tsai TJ; Chen YM; Duffield JS; Lin SL
Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
[TBL] [Abstract][Full Text] [Related]
10. Pericytes in kidney fibrosis.
Ren S; Duffield JS
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):471-80. PubMed ID: 23722183
[TBL] [Abstract][Full Text] [Related]
11. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.
Ren S; Johnson BG; Kida Y; Ip C; Davidson KC; Lin SL; Kobayashi A; Lang RA; Hadjantonakis AK; Moon RT; Duffield JS
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1440-5. PubMed ID: 23302695
[TBL] [Abstract][Full Text] [Related]
12. Host responses in tissue repair and fibrosis.
Duffield JS; Lupher M; Thannickal VJ; Wynn TA
Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor receptor-β (PDGFRβ) lineage tracing highlights perivascular cell to myofibroblast transdifferentiation during post-traumatic osteoarthritis.
Sono T; Hsu CY; Negri S; Miller S; Wang Y; Xu J; Meyers CA; Peault B; James AW
J Orthop Res; 2020 Nov; 38(11):2484-2494. PubMed ID: 32134140
[TBL] [Abstract][Full Text] [Related]
14. Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury.
Leaf IA; Nakagawa S; Johnson BG; Cha JJ; Mittelsteadt K; Guckian KM; Gomez IG; Altemeier WA; Duffield JS
J Clin Invest; 2017 Jan; 127(1):321-334. PubMed ID: 27869651
[TBL] [Abstract][Full Text] [Related]
15. Novel Mechanism of the Pericyte-Myofibroblast Transition in Renal Interstitial Fibrosis: Core Fucosylation Regulation.
Wang N; Deng Y; Liu A; Shen N; Wang W; Du X; Tang Q; Li S; Odeh Z; Wu T; Lin H
Sci Rep; 2017 Dec; 7(1):16914. PubMed ID: 29209018
[TBL] [Abstract][Full Text] [Related]
16. Kidney pericytes: a novel therapeutic target in interstitial fibrosis.
Smith SW; Schrimpf C; Parekh DJ; Venkatachalam M; Duffield JS
Histol Histopathol; 2012 Dec; 27(12):1503-14. PubMed ID: 23059881
[TBL] [Abstract][Full Text] [Related]
17. Exogenous bone marrow derived-putative endothelial progenitor cells attenuate ischemia reperfusion-induced vascular injury and renal fibrosis in mice dependent on pericytes.
Wang M; Xu H; Li Y; Cao C; Zhu H; Wang Y; Zhao Z; Pei G; Zhu F; Yang Q; Deng X; Zhou C; Guo Y; Wu J; Liao W; Yang J; Yao Y; Zeng R
Theranostics; 2020; 10(26):12144-12157. PubMed ID: 33204334
[No Abstract] [Full Text] [Related]
18. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.
Lin SL; Chang FC; Schrimpf C; Chen YT; Wu CF; Wu VC; Chiang WC; Kuhnert F; Kuo CJ; Chen YM; Wu KD; Tsai TJ; Duffield JS
Am J Pathol; 2011 Feb; 178(2):911-23. PubMed ID: 21281822
[TBL] [Abstract][Full Text] [Related]
19. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis.
Rajkumar VS; Howell K; Csiszar K; Denton CP; Black CM; Abraham DJ
Arthritis Res Ther; 2005; 7(5):R1113-23. PubMed ID: 16207328
[TBL] [Abstract][Full Text] [Related]
20. [Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease].
Nakagawa S
Yakugaku Zasshi; 2017; 137(11):1355-1360. PubMed ID: 29093371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
